In the last trading session, 0.13 million Fractyl Health Inc (NASDAQ:GUTS) shares changed hands as the company’s beta touched 0. With the company’s per share price at $1.92 changed hands at $0.02 or 1.05% during last session, the market valuation stood at $89.95M. GUTS’s last price was a discount, traded about -655.21% off its 52-week high of $14.50. The share price had its 52-week low at $1.74, which suggests the last value was 9.37% up since then. When we look at Fractyl Health Inc’s average trading volume, we note the 10-day average is 0.35 million shares, with the 3-month average coming to 316.66K.
Analysts gave the Fractyl Health Inc (GUTS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GUTS as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Fractyl Health Inc’s EPS for the current quarter is expected to be -0.44.
Fractyl Health Inc (NASDAQ:GUTS) trade information
Instantly GUTS was in green as seen at the end of in last trading. With action -7.20%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -85.45%, with the 5-day performance at -7.20% in the red. However, in the 30-day time frame, Fractyl Health Inc (NASDAQ:GUTS) is -10.53% down. Looking at the short shares, we see there were 2.24 million shares sold at short interest cover period of 5.48 days.
Fractyl Health Inc (GUTS) estimates and forecasts
Data shows that the Fractyl Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -57.11% over the past 6 months, a 94.83% in annual growth rate that is considerably higher than the industry average of 16.40%. Year-over-year growth is forecast to reach -16.67% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 10k.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -126.07%. The 2024 estimates are for Fractyl Health Inc earnings to increase by 96.33%.
GUTS Dividends
Fractyl Health Inc is expected to release its next quarterly earnings report in January.
